Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CareDx Inc

    NASDAQ: CDNA · Real-Time Price · USD
    16.99
    0.43 (2.60%)
    At close: May 30, 2025, 3:59 PM
    17.07
    0.47%
    After-hours: May 30, 2025, 04:34 PM EDT
    2.60%
    Bid 16.26
    Market Cap 946.01M
    Revenue (ttm) 346.42M
    Net Income (ttm) 58.85M
    EPS (ttm) 1.12
    PE Ratio (ttm) 15.17
    Forward PE 97.38
    Analyst Buy
    Ask 18
    Volume 959,210
    Avg. Volume (20D) 998,003
    Open 16.49
    Previous Close 16.56
    Day's Range 16.27 - 17.06
    52-Week Range 12.90 - 34.84
    Beta 2.28

    About CDNA

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol CDNA
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for CDNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    3 months ago
    +11.16%
    CareDx shares are trading higher after Chevy Chase... Unlock content with Pro Subscription
    7 months ago
    -15.84%
    CareDx shares are trading lower. The company reported preliminary Q3 financial results.
    news image

    1 week ago · businesswire.com

    Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders

    SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. (NASDAQ: CDNA) for...

    news image

    2 weeks ago · businesswire.com

    CareDx to Participate in Upcoming Investor Conferences

    BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinical...

    news image

    1 month ago · seekingalpha.com

    CareDx, Inc (CDNA) Q1 2025 Earnings Call Transcript

    CareDx, Inc (NASDAQ:CDNA ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Company Participants Caroline Corner - Investor Relations John Hanna - President & Chief Executive Officer Robert ...

    news image

    1 month ago · zacks.com

    CareDx (CDNA) Tops Q1 Earnings Estimates

    CareDx (CDNA) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.03 per share a year ago.

    news image

    1 month ago · businesswire.com

    CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting

    BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinical...

    news image

    1 month ago · businesswire.com

    CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

    BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ (“CareDx” or the “Company”)— a leading precision medicine company focused on the discovery, development, and co...

    news image

    1 month ago · businesswire.com

    CareDx to Report First Quarter 2025 Financial Results

    BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcar...

    news image

    2 months ago · businesswire.com

    CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

    NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its...

    news image

    2 months ago · businesswire.com

    CareDx Launches Two Expanded Indications for AlloSure Testing Services

    BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinical...

    Add to Watchlist